"Efficacy and Safety of Phlai Capsule Compared to Placebo as the Treatment in Allergic Rhinitis Patients"
Last updated on July 2021Recruitment
- Recruitment Status
- Recruiting
- Estimated Enrollment
- 273
Summary
- Conditions
- Allergic Rhinitis
- Type
- Interventional
- Phase
- Phase 3
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentIntervention Model Description: Participant in each arm will take medication provided by care providers who also do not know what kind of this medicationMasking: Double (Participant, Care Provider)Masking Description: Participant, care provider and investigator, outcomes assessor in each site do not know what kind of medication in each package.Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 50 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04182919
- Collaborators
- Government Pharmaceutical Organization
- Investigators
- Not Provided